| 000 | 01480 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515161108.0 | ||
| 264 | 0 | _c20090305 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(09)60403-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRosenson, Robert S | |
| 245 | 0 | 0 |
_aEffects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cFeb 2009 |
||
| 300 |
_a649-58 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipoproteins _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhospholipases A2, Secretory _xantagonists & inhibitors |
| 700 | 1 | _aHislop, Colin | |
| 700 | 1 | _aMcConnell, Daniel | |
| 700 | 1 | _aElliott, Michael | |
| 700 | 1 | _aStasiv, Yuri | |
| 700 | 1 | _aWang, Nan | |
| 700 | 1 | _aWaters, David D | |
| 773 | 0 |
_tLancet (London, England) _gvol. 373 _gno. 9664 _gp. 649-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(09)60403-7 _zAvailable from publisher's website |
| 999 |
_c18674084 _d18674084 |
||